318
Views
5
CrossRef citations to date
0
Altmetric
Articles

Sleeping Patterns in Patients with Opioid Use Disorder: Effects of Opioid Maintenance Treatment and Detoxification

, Ph.D., , M.D., , M.D., , M.D., , M.D., , M.D., , M.D., , M.D., , M.D., , M.D., , Ph.D., , M.D., , M.D. & , M.D. show all
Pages 203-210 | Received 30 Jan 2019, Accepted 27 Oct 2019, Published online: 17 Apr 2020

References

  • Backhaus, J., K. Junghanns, A. Broocks, D. Riemann, and F. Hohagen. 2002. Test–retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. Journal of Psychosomatic Research 53 (3):737–40. doi:10.1016/S0022-3999(02)00330-6.
  • Beswick, T., D. Best, S. Rees, J. Bearn, M. Gossop, and J. Strang. 2003. Major disruptions of sleep during treatment of the opiate withdrawal syndrome: Differences between methadone and lofexidine detoxification treatments. Addiction Biology 8 (1):49–57. doi:10.1080/1355621031000069882.
  • Brower, K. J., and B. E. Perron. 2010. Sleep disturbance as a universal risk factor for relapse in addictions to psychoactive substances. Medical Hypotheses 74 (5):928–33. doi:10.1016/j.mehy.2009.10.020.
  • Buysse, D. J., C. F. Reynolds 3rd, T. H. Monk, S. R. Berman, and D. J. Kupfer. 1989. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Research 28 (2):193–213. doi:10.1016/0165-1781(89)90047-4.
  • Caldwell, J. R., R. J. Rapoport, J. C. Davis, H. L. Offenberg, H. W. Marker, S. H. Roth, W. Yuan, L. Eliot, N. Babul, and P. M. Lynch. 2002. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: Results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. Journal of Pain and Symptom Management 23 (4):278–91. doi:10.1016/S0885-3924(02)00383-4.
  • Coffey, A. A., Z. Guan, P. S. Grigson, and J. Fang. 2015. Reversal of the sleep-wake cycle by heroin self-administration in rats. Brain Research Bulletin. doi:10.1016/j.brainresbull.2015.09.008.
  • Crönlein, T., B. Langguth, R. Popp, H. Lukesch, C. Pieh, G. Hajak, and P. Geisler. 2013a. Regensburg Insomnia Scale (RIS): A new short rating scale for the assessment of psychological symptoms and sleep in insomnia; study design: Development and validation of a new short self-rating scale in a sample of 218 patients suffering from insomnia and 94 healthy controls. Health and Quality of Life Outcomes 11:65. doi:10.1186/1477-7525-11-65.
  • Crönlein, T., B. Langguth, R. Popp, H. Lukesch, C. Pieh, G. Hajak, and P. Geisler. 2013b. Regensburg Insomnia Scale (RIS): A new short rating scale for the assessment of psychological symptoms and sleep in insomnia; Study design: Development and validation of a new short self-rating scale in a sample of 218 patients suffering from insomnia and 94 healthy controls. Health and Quality of Life Outcomes 11 (1):1–8. doi:10.1186/1477-7525-11-65.
  • Dimsdale, J. E., D. Norman, D. DeJardin, and M. S. Wallace. 2007. The effect of opioids on sleep architecture. Journal of Clinical Sleep Medicine 3 (1):33–36.
  • Dunn, K. E., P. H. Finan, D. Andrew Tompkins, and E. C. Strain. 2018. Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients. Addictive Behaviors 76:8–14. doi:10.1016/j.addbeh.2017.07.016.
  • Farney, R. J., A. M. McDonald, K. M. Boyle, G. L. Snow, R. T. Nuttall, M. F. Coudreaut, T. J. Wander, and J. M. Walker. 2013. Sleep disordered breathing in patients receiving therapy with buprenorphine/naloxone. European Respiratory Journal 42 (2):394–403. doi:10.1183/09031936.00120012.
  • Gillin, J. C. 1998. Are sleep disturbances risk factors for anxiety, depressive and addictive disorders? Acta Psychiatrica Scandinavica 393:39–43. doi:10.1111/j.1600-0447.1998.tb05965.x.
  • Gossop, M., and B. Bradley. 1984. Insomnia among addicts during supervised withdrawal from opiates: A comparison of oral methadone and electrostimulation. Drug and Alcohol Dependence 13 (2):191–98. doi:10.1016/0376-8716(84)90058-9.
  • Hartwell, E. E., J. G. Pfeifer, J. L. McCauley, M. Moran-Santa Maria, and S. E. Back. 2014. Sleep disturbances and pain among individuals with prescription opioid dependence. Addictive Behaviors 39 (10):1537–42. doi:10.1016/j.addbeh.2014.05.025.
  • Howe, R. C., F. W. Hegge, and J. L. Phillips. 1980. Acute heroin abstinence in man: I. Changes in behavior and sleep. Drug and Alcohol Dependence 5 (5):341–56. doi:10.1016/0376-8716(80)90160-X.
  • Hsu, W. Y., N. Y. Chiu, J. T. Liu, C. H. Wang, T. G. Chang, Y. C. Liao, and P. I. Kuo. 2012. Sleep quality in heroin addicts under methadone maintenance treatment. Acta Neuropsychiatrica 24 (6):356–60. doi:10.1111/j.1601-5215.2011.00628.x.
  • Liao, Y., J. Tang, T. Liu, X. Chen, T. Luo, and W. Hao. 2011. Sleeping problems among Chinese heroin-dependent individuals. The American Journal of Drug and Alcohol Abuse 37 (3):179–83. doi:10.3109/00952990.2010.535580.
  • Lydon-Staley, D. M., H. H. Cleveland, A. S. Huhn, M. J. Cleveland, J. Harris, D. Stankoski, E. Deneke, R. E. Meyer, and S. C. Bunce. 2017. Daily sleep quality affects drug craving, partially through indirect associations with positive affect, in patients in treatment for nonmedical use of prescription drugs. Addictive Behaviors 65:275–82. doi:10.1016/j.addbeh.2016.08.026.
  • Md, R. S., M. M. Md Jafar, H. Md Sharareh, H. R. Md Maryam, and E. Ma Masoumeh. 2015. The Effect of Cognitive Behavior Therapy in Insomnia due to Methadone Maintenance Therapy: A Randomized Clinical Trial. Iranian Journal of Medical Sciences 40 (5):396–403.
  • Ohayon, M. M. 2002. Epidemiology of insomnia: What we know and what we still need to learn. Sleep Medicine Reviews 6 (2):97–111. doi:10.1053/smrv.2002.0186.
  • Oyefeso, A., P. Sedgwick, and H. Ghodse. 1997. Subjective sleep-wake parameters in treatment-seeking opiate addicts. Drug and Alcohol Dependence 48 (1):9–16. doi:10.1016/S0376-8716(97)00097-5.
  • Palagini, L., C. Baglioni, A. Ciapparelli, A. Gemignani, and D. Riemann. 2013. REM sleep dysregulation in depression: State of the art. Sleep Medicine Reviews 17 (5):377–90. doi:10.1016/j.smrv.2012.11.001.
  • Panagiotou, I., and K. Mystakidou. 2012. Non-analgesic effects of opioids: Opioids’ effects on sleep (including sleep apnea). Current Pharmaceutical Design 18 (37):6025–33. doi:10.2174/138161212803582450.
  • Peles, E., S. Schreiber, and M. Adelson. 2006. Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients. Drug and Alcohol Dependence 82 (2):103–10. doi:10.1016/j.drugalcdep.2005.08.011.
  • Peles, E., S. Schreiber, and M. Adelson. 2009. Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose. European Neuropsychopharmacology 19 (8):581–88. doi:10.1016/j.euroneuro.2009.04.001.
  • Peles, E., S. Schreiber, R. Hamburger, and M. Adelson. 2011. No change of sleep after 6 and 12 months of methadone maintenance treatment. Journal of Addiction Medicine 5 (2):141–47. doi:10.1097/ADM.0b013e3181e8b6c4.
  • Rose, A. R., P. G. Catcheside, R. D. McEvoy, D. Paul, D. Kapur, E. Peak, A. Vakulin, and N. A. Antic. 2014. Sleep disordered breathing and chronic respiratory failure in patients with chronic pain on long term opioid therapy. Journal of Clinical Sleep Medicine 10 (8):847–52. doi:10.5664/jcsm.3950.
  • Schwarzer, A., M. Aichinger-Hinterhofer, C. Maier, J. Vollert, and J. W. Walther. 2015. Sleep-disordered breathing decreases after opioid withdrawal: Results of a prospective controlled trial. Pain 156 (11):2167–74. doi:10.1097/j.pain.0000000000000279.
  • Sharkey, K. M., M. E. Kurth, B. J. Anderson, R. P. Corso, R. P. Millman, and M. D. Stein. 2011. Assessing sleep in opioid dependence: A comparison of subjective ratings, sleep diaries, and home polysomnography in methadone maintenance patients. Drug and Alcohol Dependence 113 (2–3):245–48. doi:10.1016/j.drugalcdep.2010.08.007.
  • Stein, M. D., D. S. Herman, S. Bishop, J. A. Lassor, M. Weinstock, J. Anthony, and B. J. Anderson. 2004. Sleep disturbances among methadone maintained patients. Journal of Substance Abuse Treatment 26 (3):175–80. doi:10.1016/s0740-5472(03)00191-0.
  • Tang, J., Y. Liao, H. He, Q. Deng, G. Zhang, C. Qi, H. Cui, B. Jiao, M. Yang, Z. Feng, et al. 2015. Sleeping problems in Chinese illicit drug dependent subjects. BMC Psychiatry 15:28. doi:10.1186/s12888-015-0409-x.
  • Wang, Q., X. F. Yue, W. M. Qu, R. Tan, P. Zheng, Y. Urade, and Z. L. Huang. 2013. Morphine inhibits sleep-promoting neurons in the ventrolateral preoptic area via mu receptors and induces wakefulness in rats. Neuropsychopharmacology 38 (5):791–801. doi:10.1038/npp.2012.244.
  • Wang, S. C., H. H. Tsou, C. H. Chen, Y. T. Chen, I. K. Ho, C. F. Hsiao, S. Y. Chou, Y. F. Lin, K. C. Fang, C. L. Huang, et al. 2012. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients. European Neuropsychopharmacology 22 (10):695–703. doi:10.1016/j.euroneuro.2012.02.002.
  • Watson, N. F., K. P. Harden, D. Buchwald, M. V. Vitiello, A. I. Pack, E. Strachan, and J. Goldberg. 2014. Sleep duration and depressive symptoms: A gene-environment interaction. Sleep 37 (2):351–58. doi:10.5665/sleep.3412.
  • Webster, L. R., Y. Choi, H. Desai, L. Webster, and B. J. Grant. 2008. Sleep-disordered breathing and chronic opioid therapy. Pain Medicine 9 (4):425–32. doi:10.1111/j.1526-4637.2007.00343.x.
  • Wesson, D. R., and W. Ling. 2003. The clinical opiate withdrawal scale (COWS). Journal of Psychoactive Drugs 35 (2):253–59. doi:10.1080/02791072.2003.10400007.
  • Wilson, L., and L. Dorosz. 1984. Possible role of the opioid peptides in sleep. Medical Hypotheses 14 (3):269–80. doi:10.1016/0306-9877(87)90128-9.
  • Wittchen, H. U., P. Krause, M. Höfler, D. Pittrow, S. Winter, B. Spiegel, G. Hajak, D. Riemann, A. Steiger, and H. Pfister. 2001. NISAS-2000: The “Nationwide Insomnia Screening and Awareness Study”. Prevalence and interventions in primary care. Fortschritte der Medizin. Originalien 119 (1):9–19.
  • Zahari, Z., M. A. Inrahim, S. C. Tan, N. Mohamad, and R. Ismail. 2016a. Sleep quality in opioid-naive and opioid-dependent patientson methadone maintenance therapy in Malaysia. Turkish Journal of Medical Sciences 46 (6):1743–48. doi:10.3906/sag-1507-132.
  • Zahari, Z., C. S. Lee, M. A. Ibrahim, N. Musa, M. A. Mohd Yasin, Y. Y. Lee, S. C. Tan, N. Mohamad, and R. Ismail. 2016b. The AC/AG Diplotype for the 118A>G and IVS2 + 691G>C polymorphisms of OPRM1 gene is associated with sleep quality among opioid-dependent patients on methadone maintenance therapy. Pain and Therapy 5 (1):43–54. doi:10.1007/s40122-016-0044-3.
  • Zahari, Z., L. C. Siong, N. Musa, M. A. Mohd Yasin, T. S. Choon, N. Mohamad, and R. Ismail. 2016c. Report: Demographic profiles and sleep quality among patients on methadone maintenance therapy (MMT) in Malaysia. Pakistan Journal of Pharmaceutical Sciences 29 (1):239–46.
  • Zheng, W. H., R. J. Wakim, R. C. Geary, L. R. Lander, S. J. Wen, M. C. Xiao, and C. R. Sullivan. 2016. Self-reported sleep improvement in Buprenorphine MAT (Medication Assisted Treatment) population. Austin Journal of Drug Abuse and Addiction 3 (1):1009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.